Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure

KR Stenmark, B Meyrick, N Galie… - … of Physiology-Lung …, 2009 - journals.physiology.org
At present, six groups of chronic pulmonary hypertension (PH) are described. Among these,
group 1 (and 1′) comprises a group of diverse diseases termed pulmonary arterial …

The monocrotaline model of pulmonary hypertension in perspective

JG Gomez-Arroyo, L Farkas… - … of Physiology-Lung …, 2012 - journals.physiology.org
Severe forms of pulmonary arterial hypertension (PAH) are characterized by various
degrees of remodeling of the pulmonary arterial vessels, which increases the pulmonary …

[HTML][HTML] Reversal of experimental pulmonary hypertension by PDGF inhibition

RT Schermuly, E Dony, HA Ghofrani… - The Journal of …, 2005 - Am Soc Clin Investig
Progression of pulmonary hypertension is associated with increased proliferation and
migration of pulmonary vascular smooth muscle cells. PDGF is a potent mitogen and …

Basic science of pulmonary arterial hypertension for clinicians: new concepts and experimental therapies

SL Archer, EK Weir, MR Wilkins - Circulation, 2010 - Am Heart Assoc
Pulmonary arterial hypertension (PAH) is a syndrome in which pulmonary arterial
obstruction increases pulmonary vascular resistance, which leads to right ventricular (RV) …

Targeted therapies in pulmonary arterial hypertension

D Montani, MC Chaumais, C Guignabert… - Pharmacology & …, 2014 - Elsevier
Pulmonary arterial hypertension (PAH) is a rare disorder characterized by progressive
obliteration of small pulmonary arteries that leads to elevated pulmonary arterial pressure …

Pathogenic mechanisms of pulmonary arterial hypertension

SY Chan, J Loscalzo - Journal of molecular and cellular cardiology, 2008 - Elsevier
Pulmonary arterial hypertension (PAH) is a complex disease that causes significant
morbidity and mortality and is clinically characterized by an increase in pulmonary vascular …

Long-term treatment with a Rho-kinase inhibitor improves monocrotaline-induced fatal pulmonary hypertension in rats

K Abe, H Shimokawa, K Morikawa, T Uwatoku… - Circulation …, 2004 - Am Heart Assoc
Primary pulmonary hypertension is a fatal disease characterized by endothelial dysfunction,
hypercontraction and proliferation of vascular smooth muscle cells (VSMCs), and migration …

Simvastatin inhibits cigarette smoking–induced emphysema and pulmonary hypertension in rat lungs

JH Lee, DS Lee, EK Kim, KH Choe, YM Oh… - American journal of …, 2005 - atsjournals.org
Rationale: In cigarette smoking–induced chronic obstructive pulmonary disease, structural
and functional derangements are characterized by parenchymal destruction and pulmonary …

Simvastatin rescues rats from fatal pulmonary hypertension by inducing apoptosis of neointimal smooth muscle cells

T Nishimura, LT Vaszar, JL Faul, G Zhao, GJ Berry… - Circulation, 2003 - Am Heart Assoc
Background—Pulmonary vascular injury by toxins can induce neointimal formation,
pulmonary arterial hypertension (PAH), right ventricular failure, and death. We showed …

The vascular bed in COPD: pulmonary hypertension and pulmonary vascular alterations

S Sakao, NF Voelkel, K Tatsumi - European respiratory review, 2014 - Eur Respiratory Soc
The loss of pulmonary vessels has been shown to be related to the severity of pulmonary
hypertension in patients with chronic obstructive pulmonary disease (COPD). The severity of …